[Furtulon (doxifluridine) in the treatment of non-small cell bronchial carcinoma].
Drings
P
P
Thoraxklinik Heidelberg-Rohrbach der LVA Baden, Abteilung Innere Medizin-Onkologie.
Calcanis
A
A
D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D005467:Floxuridine / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D000970:Antineoplastic Agents; D005467:Floxuridine; C025034:doxifluridine
Furtulon (Doxifluridin) in der Behandlung des nichtkleinzelligen Bronchialkarzinoms.